News

Burnet's NHMRC success rate among Australia's best

Angus Morgan

09 November, 2015

Melissa_churchill_nih_grant

Associate Professor Melissa Churchill (centre, pictured with Professor Sharon Lewin and Professor Paul Gorry), received two significant NHMRC grants.

Burnet Institute researchers have been awarded $5.5 million in the National Health and Medical Research Council (NHMRC) grants scheme at a success rate among Australia’s best.

The grants are among $630 million in NHMRC funding for 836 projects nationally announced today by Federal Health Minister, Sussan Ley.

Burnet Institute Director and CEO, Professor Brendan Crabb AC said the Institute’s success rate for project grant applications, at 26 per cent, was double the national average.

Burnet’s overall success rate for projects and fellowships was higher still at 29 per cent.

“That will place us close enough to the top administering institution in the country for the third year in a row,” Professor Crabb said.

“There’s a lot of strength and good opportunities for the next round. And we must celebrate that for the third year in a row, grants were awarded to all three Burnet centres.”

The Burnet grants include two for Associate Professor Melissa Churchill to support her research into HIV infection of the central nervous system and its implications for the development of HIV-associated neurocognitive disorders.

NHMRC CEO Professor Anne Kelso said the grants would support Australia’s best new and established researchers in the health and medical research sector.

“They support discovery and innovation, development and clinical trials of new therapies and public health interventions, and improvements in health care delivery,” Professor Kelso said.

NHMRC Project Grants for 2016

Associate Professor Melissa Churchill - $762,491
HIV Phenotypes Important for the Establishment of Persistent Reservoirs in the Central Nervous System and which impact Neurotropism and Neuropathogenesis.

Associate Professor Melissa Churchill - $847,520
Viral Determinants of HIV-1 Transcriptional Latency in the Central Nervous System:
Impact on Cure Strategies

Professor Andre Renzaho – $1,558,515
Integrated solutions for healthy birth, growth, and development: A cluster-randomized controlled trial to evaluate the effectiveness of a mixed nutrition intervention package in reducing child undernutrition in Lao People’s Democratic Republic

Associate Professor Heidi Drummer - $372,972
Profiling the specificity of the neutralizing antibody response in people who have long term protection from developing chronic HCV

Associate Professor Anthony Jaworowski – $632,037
A new monocyte atherogenic phenotype in chronic HIV disease

Research Fellowships

Professor Paul Dietze - $124,531
Innovative approaches to alcohol and drug problems in Australia

Professor Margaret Hellard - $851,980
Reducing the impact of blood borne viruses and sexually transmitted infections in young people

Early Career Fellowship

Dr James McMahon - $344,364
Enhancing the cascade of HIV care to maximise the prevention benefits of antiretroviral therapy for populations living with HIV

Contact Details

For more information in relation to this news article, please contact:

Professor Brendan Crabb AC

Director and CEO; Co-Head Malaria Research Laboratory; Chair, Victorian Chapter of the Association of Australian Medical Research Institutes (AAMRI)

Telephone

+61392822174

Email

brendan.crabb@burnet.edu.au

Subscribe to News

Subscribe to receive our latest news: